Department of Pharmacy, Faculty of Science, National University of Singapore.
Diabet Med. 2012 Sep;29(9):e338-44. doi: 10.1111/j.1464-5491.2012.03733.x.
A reliable and valid measure is essential for the assessment of medication adherence. Until now, no patient-reported medication adherence measure has been validated in Singapore. The aim of this study was to validate a modified 4-item Morisky-Green-Levine Medication Adherence Scale in patients with Type 2 diabetes in Singapore.
A cross-sectional survey was conducted in a sample of outpatients with Type 2 diabetes in Singapore from September to December in 2009. Respondents completed either an English or Chinese version of the modified 4-item Morisky-Green-Levine Medication Adherence Scale. The scale scores ranged from 0 to 4, with higher scores indicating better medication adherence. Reliability was assessed using Cronbach's alpha. Content validity was assessed by expert review. Construct validity was examined using factor analysis and hypothesis testing.
Of the 294 respondents who completed the modified Morisky-Green-Levine Medication Adherence Scale, 13.3, 21.4, 35.7 and 29.6% had a score of 0-1, 2, 3 and 4, respectively. The internal consistency of the scale was moderate (Cronbach's alpha = 0.62). Principal component analysis showed that the four items loaded onto one factor (eigenvalue = 1.95). Respondents with higher scores were older (P < 0.001), had lower HbA(1c) levels (P < 0.001) and had better adherence to physician-recommended diet (P < 0.001) and physical exercise (P = 0.02).
The psychometric properties of the modified Morisky-Green-Levine Medication Adherence Scale were less than satisfactory. A ceiling effect was observed. The scale may not be an adequate measure to assess medication adherence in patients with Type 2 diabetes in Singapore. Future research could target refining the scale and investigating its use in other patient populations.
评估药物依从性需要可靠和有效的衡量标准。到目前为止,还没有针对新加坡患者的经过验证的患者报告药物依从性衡量标准。本研究的目的是验证在新加坡 2 型糖尿病患者中经过修改的 Morisky-Green-Levine 药物依从性 4 项量表。
2009 年 9 月至 12 月在新加坡的 2 型糖尿病门诊患者中进行了横断面调查。受访者完成了经过修改的 Morisky-Green-Levine 药物依从性 4 项量表的英文或中文版本。量表评分为 0 至 4 分,得分越高表示药物依从性越好。使用 Cronbach's alpha 评估信度。内容效度通过专家评审评估。通过因子分析和假设检验检验结构效度。
在完成经过修改的 Morisky-Green-Levine 药物依从性量表的 294 名受访者中,分别有 13.3%、21.4%、35.7%和 29.6%的人得分为 0-1、2、3 和 4。量表的内部一致性中等(Cronbach's alpha = 0.62)。主成分分析显示,四个项目加载到一个因子上(特征值= 1.95)。得分较高的患者年龄较大(P < 0.001),糖化血红蛋白(HbA(1c))水平较低(P < 0.001),并更遵守医生推荐的饮食(P < 0.001)和体育锻炼(P = 0.02)。
修改后的 Morisky-Green-Levine 药物依从性量表的心理测量特性不太令人满意。观察到上限效应。该量表可能不是评估新加坡 2 型糖尿病患者药物依从性的充分衡量标准。未来的研究可以针对完善该量表并研究其在其他患者人群中的应用。